These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 9267429)
1. Antagonistic effect of human alpha-1-antitrypsin on excystation of Cryptosporidium parvum oocysts. Forney JR; Yang S; Healey MC J Parasitol; 1997 Aug; 83(4):771-4. PubMed ID: 9267429 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of serine protease inhibitors against Cryptosporidium parvum infection in a bovine fallopian tube epithelial cell culture system. Forney JR; Yang S; Du C; Healey MC J Parasitol; 1996 Aug; 82(4):638-40. PubMed ID: 8691375 [TBL] [Abstract][Full Text] [Related]
3. Interaction of the human serine protease inhibitor alpha-1-antitrypsin with Cryptosporidium parvum. Forney JR; Yang S; Healey MC J Parasitol; 1996 Jun; 82(3):496-502. PubMed ID: 8636860 [TBL] [Abstract][Full Text] [Related]
4. [Highly Active AntiRetroviral Therapy and cryptosporidiosis]. Morales Gomez MA Parassitologia; 2004 Jun; 46(1-2):95-9. PubMed ID: 15305695 [TBL] [Abstract][Full Text] [Related]
5. Protease activity associated with excystation of Cryptosporidium parvum oocysts. Forney JR; Yang S; Healey MC J Parasitol; 1996 Dec; 82(6):889-92. PubMed ID: 8973395 [TBL] [Abstract][Full Text] [Related]
6. Statistical comparison of excystation methods in Cryptosporidium parvum oocysts. Pecková R; Stuart PD; Sak B; Květoňová D; Kváč M; Foitová I Vet Parasitol; 2016 Oct; 230():1-5. PubMed ID: 27884435 [TBL] [Abstract][Full Text] [Related]
7. Chemical and physical factors affecting the excystation of Cryptosporidium parvum oocysts. Kato S; Jenkins MB; Ghiorse WC; Bowman DD J Parasitol; 2001 Jun; 87(3):575-81. PubMed ID: 11426720 [TBL] [Abstract][Full Text] [Related]
8. Synergistic anticryptosporidial potential of the combination alpha-1-antitrypsin and paromomycin. Forney JR; Yang S; Healey MC Antimicrob Agents Chemother; 1997 Sep; 41(9):2006-8. PubMed ID: 9303402 [TBL] [Abstract][Full Text] [Related]
9. Comparison of Cryptosporidium parvum development in various cell lines for screening in vitro drug testing. Siripanth C; Punpoowong B; Amarapal P; Thima N; Eampokalap B; Kaewkungwal J Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):540-6. PubMed ID: 15689063 [TBL] [Abstract][Full Text] [Related]
10. The utilization of sodium taurocholate in excystation of Cryptosporidium parvum and infection of tissue culture. Gold D; Stein B; Tzipori S J Parasitol; 2001 Oct; 87(5):997-1000. PubMed ID: 11695421 [TBL] [Abstract][Full Text] [Related]
11. Combination of cell culture and quantitative PCR (cc-qPCR) to assess disinfectants efficacy on Cryptosporidium oocysts under standardized conditions. Shahiduzzaman M; Dyachenko V; Keidel J; Schmäschke R; Daugschies A Vet Parasitol; 2010 Jan; 167(1):43-9. PubMed ID: 19850414 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of two commercial disinfectants on the viability and infectivity of Cryptosporidium parvum oocysts. Castro-Hermida JA; Pors I; Méndez-Hermida F; Ares-Mazás E; Chartier C Vet J; 2006 Mar; 171(2):340-5. PubMed ID: 16490718 [TBL] [Abstract][Full Text] [Related]
13. Excystation of Cryptosporidium parvum at temperatures that are reached during solar water disinfection. Gómez-Couso H; Fontán-Sainz M; Fernández-Alonso J; Ares-Mazás E Parasitology; 2009 Apr; 136(4):393-9. PubMed ID: 19195413 [TBL] [Abstract][Full Text] [Related]
14. The efficacy of three common hospital liquid germicides to inactivate Cryptosporidium parvum oocysts. Wilson JA; Margolin AB J Hosp Infect; 1999 Jul; 42(3):231-7. PubMed ID: 10439996 [TBL] [Abstract][Full Text] [Related]
15. Comparison of viability and infectivity of Cryptosporidium parvum oocysts stored in potassium dichromate solution and chlorinated tap water. Chen F; Huang K; Qin S; Zhao Y; Pan C Vet Parasitol; 2007 Nov; 150(1-2):13-7. PubMed ID: 17954011 [TBL] [Abstract][Full Text] [Related]
16. Effect of hydrogen peroxide and other protease inhibitors on Cryptosporidium parvum excystation and in vitro development. Kniel KE; Sumner SS; Pierson MD; Zajac AM; Hackney CR; Fayer R; Lindsay DS J Parasitol; 2004 Aug; 90(4):885-8. PubMed ID: 15357093 [TBL] [Abstract][Full Text] [Related]
17. An improved in vitro infection model for viability testing of Cryptosporidium parvum oocysts. Najdrowski M; Joachim A; Daugschies A Vet Parasitol; 2007 Nov; 150(1-2):150-4. PubMed ID: 17949908 [TBL] [Abstract][Full Text] [Related]
18. Improvement of in vitro evaluation of chemical disinfectants for efficacy on Cryptosporidium parvum oocysts. Delling C; Lendner M; Müller U; Daugschies A Vet Parasitol; 2017 Oct; 245():5-13. PubMed ID: 28969838 [TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of selenium on Cryptosporidium parvum infection in vitro and in vivo. Huang K; Yang S Biol Trace Elem Res; 2002; 90(1-3):261-72. PubMed ID: 12666840 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of amine-based disinfectant KENO™COX on the infectivity of Cryptosporidium parvum oocysts. Naciri M; Mancassola R; Fort G; Danneels B; Verhaeghe J Vet Parasitol; 2011 Jun; 179(1-3):43-9. PubMed ID: 21354705 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]